Stable cannabinoid formulations
US11224660B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2015 |
| Grant date | Jan 18, 2022 |
| Priority date | — |
| Expiry date | May 28, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.